Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

Fresenius Kabi USA is voluntarily recalling two plenty of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (four mcg / mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall attributable to the potential of a hint quantity of lidocaine current in these two tons and our investig



Source link